Baxter price target lowered to $54 from $58 at Barclays

Barclays analyst Matt Miksic lowered the firm’s price target on Baxter to $54 from $58 and keeps an Overweight rating on the shares. The analyst trimmed estimates following the earnings beat to reflect the BPS divestiture closing in Q3. While Baxter’s new guidance is more a bit more complex, the company’s continuing operations performance is a “solid positive,” the analyst tells investors in a research note.